Skip to main content
Log in

Inhibitory Effect of Interferons on Contractive Activity of Bovine Mesenteric Lymphatic Vessels and Nodes

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

We studied the effect of IFNα-2b and IFNβ-1a on phasic and tonic contractions of isolated bovine mesenteric lymphatic vessels and nodes. IFNα-2b and IFNβ-1a in concentrations of 250-1000 U/ml produced dose-dependent negative chronotropic and inotropic effects on spontaneous phasic contractions and tonus of lymphatic vessels and nodes. In de-endothelialized lymphatic vessels and nodes, IFNα-2b and IFNβ-1a in the same concentrations had less pronounced inhibitory effect on spontaneous contraction and tonus. L-NAME (100 μM) and charybdotoxin (0.1 μM with 0.5 μM apamine) significantly attenuated the inhibitory effect of IFNα-2b on phasic and tonic contractions of lymph nodes. L-NAME (100 μM) and indomethacin (10 μM) significantly reduced the IFNα-2b-induced inhibitory effect on phasic and tonic contractions of lymph node. These results indicate that IFNα-2b and IFNβ-1a have a pronounced inhibitory effect on the phasic and tonic contractions of bovine mesenteric lymphatic vessels and nodes. The responses are endothelium-dependent and are determined by production of NO and endothelium-dependent hyperpolarizing factor by endotheliocytes in lymphatic vessels and by production of NO and prostacyclin by endotheliocytes in the lymphatic nodes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lobov GI, Pan’kova MN. Effect of histamine on contractile activity of smooth muscles in bovine mesenteric lymph nodes. Bull. Exp. Biol. Med. 2012;152(4):406-408.

    Article  CAS  PubMed  Google Scholar 

  2. Lobov GI, Pan’kova MN. Lymph transport in lymphatic nodes: mechanisms of regulation. Ross. Fiziol. Zh. 2012;98(11):1350-1361. Russian.

    CAS  Google Scholar 

  3. Bosinger SE, Utay NS. Type I interferon: understanding its role in HIV pathogenesis and therapy. Curr. HIV/AIDS Rep. 2015;12(1):41-53.

    Article  PubMed  Google Scholar 

  4. Campbell WB, Gauthier KM. What is new in endotheliumderived hyperpolarizing factors? Curr. Opin. Nephrol. Hypertens. 2002;11(2):177-183.

    Article  PubMed  Google Scholar 

  5. Dong Y, Watabe H, Cui J, Abe S, Sato N, Ishikawa H, Yoshitomi T. Reduced effects of endothelium-derived hyperpolarizing factor in ocular ciliary arteries from spontaneous hypertensive rats. Exp. Eye Res. 2010;90(2):324-329.

    Article  CAS  PubMed  Google Scholar 

  6. Fabrizi F, Dixit V, Messa P, Martin P. Pegylated Interferon mono-therapy of chronic hepatitis C in the dialysis population: systematic review and meta-analysis. Ther. Apher. Dial. 2015;19(6):611-621.

    Article  CAS  PubMed  Google Scholar 

  7. Frömel T, Fleming I. Whatever happened to the epoxyeicosatrienoic Acid-like endothelium-derived hyperpolarizing factor? The identification of novel classes of lipid mediators and their role in vascular homeostasis. Antioxid. Redox Signal. 2015;22(14):1273-1292.

    Article  PubMed  Google Scholar 

  8. Jin X, Satoh-Otonashi Y, Zamami Y, Takatori S, Hashikawa-Hobara N, Kitamura Y, Kawasaki H. New molecular mechanisms for cardiovascular disease: contribution of endotheliumderived hyperpolarizing factor in the regulation of vasoconstriction in peripheral resistance arteries. J. Pharmacol. Sci. 2011;116(4):332-336.

    Article  CAS  PubMed  Google Scholar 

  9. Luksha L, Agewall S, Kublickiene K. Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease. Atherosclerosis. 2009;202(2):330-344.

  10. Martinez-León JB, Segarra G, Medina P, Vila JM, Lluch P, Peiró M, Otero E, Lluch S. Ca2+-activated K+ channels mediate relaxation of forearm veins in chronic renal failure. J. Hypertens. 2003;21(10):1927-1934.

    Article  PubMed  Google Scholar 

  11. Sano E, Tashiro S, Tsumoto K, Ueda T. Differential effects of IFN-β on the survival and growth of human vascular smooth muscle and endothelial cells. Biores. Open Access. 2015;4(1):1-15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Yeh ML, Peng CY, Dai CY, Lai HC, Huang CF, Hsieh MY, Huang JF, Chen SC, Lin ZY, Yu ML, Chuang WL. Pegylatedinterferon alpha therapy for treatment-experienced chronic hepatitis B patients. PLoS One. 2015;10(4):e0122259. doi: https://doi.org/10.1371/journal.pone.0122259.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Zawieja DC. Contractile physiology of lymphatics. Lymphat. Res. Biol. 2009;7(2):87-96.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. I. Lobov.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 164, No. 8, pp. 145-149, August, 2017

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Unt, D.V., Lobov, G.I. Inhibitory Effect of Interferons on Contractive Activity of Bovine Mesenteric Lymphatic Vessels and Nodes. Bull Exp Biol Med 164, 123–126 (2017). https://doi.org/10.1007/s10517-017-3939-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-017-3939-z

Key Words

Navigation